Michael Profile picture
Marketing Professional | Amateur Investor (Not financial advice) $IREN $ZETA analysis 👇
Mar 11 7 tweets 1 min read
Elevance Health $ELV just spoke at the Barclays Global Healthcare Conference.

A few things stood out: strong financial outlook, a regulatory dispute with CMS, and a big push into AI across the business.

Here are the key takeaways. 👇 Elevance reaffirmed its 2026 outlook with:

• Adjusted EPS of at least $25.50
• At least $5.5B in operating cash flow

Considering the misses from insurers as of late this is a good sign.